Bastion Therapeutics
Company

Bastion Therapeutics

Biotechnology Research Space, United Kingdom 3 employees
Employees
3

Bastion Therapeutics Overview

Headquarters
Space, United Kingdom
Industry
Biotechnology Research
Employees
3
Funding
840.0K
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Bastion Therapeutics

Bastion Therapeutics was a biotech co-founded by Nia Emami. Our mission was to develop novel Treg cell therapies for inflammatory disorders with high unmet need. We used our proprietary GRIT™ platform to engineer Tregs that modulate the immune system and overcome key limitations of earlier approaches. Our goal was to create therapies that are safe, durable, and truly effective for patients. Bastion Therapeutics concluded operations in December 2024.

Bastion Therapeutics Contact Details

People in AeroLeads
1

Bastion Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Melika Parva Business Development Manager L Angel Investor
View

Compare Similar Companies to Bastion Therapeutics